The caries process in dentin involves the degradation of both mineral and organic matrix. The demineralization has been demonstrated to be caused by bacterial acids. However, the collagen degradation is considered to be initiated by endogenous proteolytic enzymes, mainly collagenolytic matrix metalloproteinases (MMPs). This paper aims to relate salivary MMP-8 (or salivary collagenase-2) and tissue inhibitor of MMP (TIMP-1) levels to manifest caries in a large number of subjects. A random sample of 451 adults (aged 18-87 years) living in the south of Sweden was included in this study. Standard clinical examinations were performed, and stimulated saliva was collected and analyzed for concentrations of MMP-8, TIMP-1 and total protein, using an immunofluorometric assay, an enzyme-linked immunosorbent assay and the Bradford assay, respectively. Salivary numbers of mutans streptococci and lactobacilli were determined using a chair-side kit. Subjects with manifest caries lesions presented with elevated levels of MMP-8 (p < 0.001) as well as total protein, MMP-8/TIMP-1 ratio, bleeding on probing and plaque index (p = 0.05) compared with subjects without manifest caries. Multiple linear regression analysis with caries as the dependent variable revealed MMP-8 as the only significant explanatory variable (p < 0.001). TIMP-1 was not significant in any case. Using MMP-8 as the dependent variable revealed total protein concentration, caries lesions (p ≤ 0.001) and salivary secretion rate (p = 0.05) as explanatory variables. In conclusion, our data reveal that subjects with manifest caries lesions have elevated levels of salivary MMP-8 relative to subjects with no caries lesions. © 2014 S. Karger AG, Basel

Keywords:
Dental caries, Dentin, Matrix metalloproteinase-8, Saliva, Tissue inhibitor of metalloproteinase-1
1.
Boushell LW, Kaku M, Mochida Y, Bagnell R, Yamauchi M: Immunohistochemical localization of matrixmetalloproteinase-2 in human coronal dentin. Arch Oral Biol 2008;53:109-116.
2.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
3.
Carrilho MR, Tay FR, Donnelly AM, Agee KA, Tjäderhane L, Mazzoni A, Breschi L, Foulger S, Pashley DH: Host-derived loss of dentin matrix stiffness associated with solubilization of collagen. J Biomed Mater Res B Appl Biomater 2009;90:373-380.
4.
Chaussain-Miller C, Fioretti F, Goldberg M, Menashi S: The role of matrix metalloproteinases (MMPs) in human caries. J Dent Res 2006;85:22-32.
5.
Collin HL, Sorsa T, Meurman JH, Niskanen L, Salo T, Rönkä H, Konttinen YT, Koivisto AM, Uusitupa M: Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. J Periodontal Res 2000;35:259-265.
6.
Dickinson DP: Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 2002;13:238-275.
7.
Gendron R, Grenier D, Sorsa T, Mayrand D: Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine. Clin Diagn Lab Immunol 1999;6:437-439.
8.
Gursoy UK, Könönen E, Pradhan-Palikhe P, Tervahartiala T, Pussinen PJ, Suominen-Taipale L, Sorsa T: Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010;37:487-493.
9.
Gursoy UK, Könönen E, Pussinen PJ, Tervahartiala T, Hyvärinen K, Suominen AL, Uitto VJ, Paju S, Sorsa T: Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis Markers 2011;30:299-305.
10.
Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Rönkä H, Tschesche H, Salo T: Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline. J Biol Chem 1997;272:31504-31509.
11.
Hannas AR, Pereira JC, Granjeiro JM, Tjäderhane L: The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 2007;65:1-13.
12.
Holten-Andersen L, Jensen SB, Bardow A, Harslund J, Thaysen-Andersen M, Lademann U, Usher PA, Offenberg H, Højrup P, Reibel J, Nielsen HJ, Brünner N, Nauntofte B: Identifying sources and estimating glandular output of salivary TIMP-1. Scand J Clin Lab Invest 2008;68:548-554.
13.
Ingman T, Sorsa T, Lindy O, Koski H, Konttinen YT: Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients. J Clin Periodontol 1994;21:26-31.
14.
Katz S, Park KK, Palenik CJ: In vitro root surface caries studies. J Oral Med 1987;42:40-48.
15.
Kidd E, Bjørndal L, Beighton D, Fejerskov O: Caries removal and the pulp-dentinal complex; in Fejerskov O, Kidd EA (eds): Dental Caries: The Disease and Its Clinical Management. Oxford, Blackwell Munksgaard, 2008.
16.
Konttinen YT, Halinen S, Hanemaaijer R, Sorsa T, Hietanen J, Ceponis A, Xu JW, Manthorpe R, Whittington J, Larsson A, Salo T, Kjeldsen L, Stenman UH, Eisen AZ: Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol 1998;17:335-347.
17.
Leonardi R, Loreto C: Immunohistochemical localization of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in human carious dentin. Acta Histochem 2010;112:298-302.
18.
Lundegren N, Axtelius B, Åkerman S: Self-perceived oral health, oral treatment need and the use of oral health care of the adult population in Skåne, Sweden. Swed Dent J 2011;35:89-98.
19.
Lundegren N, Axtelius B, Åkerman S: Oral health in the adult population of Skåne, Sweden: a clinical study. Acta Odontol Scand 2012;70:511-519.
20.
Mäkelä M, Salo T, Uitto VJ, Larjava H: Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994;73:1397-1406.
21.
Mazzoni A, Breschi L, Carrilho M, Nascimento FD, Orsini G, Ruggeri A, Gobbi P, Manzoli L, Tay FR, Pashley DH, Tjäderhane L: A review of the nature, role, and function of dentin non-collagenous proteins. Part II. Enzymes, serum proteins, and growth factors. Endod Topics 2009;21:19-40.
22.
Mazzoni A, Scaffa P, Carrilho M, Tjäderhane L, Di Lenarda R, Polimeni A, Tezvergil-Mutluay A, Tay FR, Pashley DH, Breschi L: Effects of etch-and-rinse and self-etch adhesives on dentin MMP-2 and MMP-9. J Dent Res 2013;92:82-86.
23.
Nascimento FD, Minciotti CL, Geraldeli S, Carrilho MR, Pashley DH, Tay FR, Nader HB, Salo T, Tjäderhane L, Tersariol IL: Cysteine cathepsins in human carious dentin. J Dent Res 2011;90:506-511.
24.
Nishitani Y, Yoshiyama M, Wadgaonkar B, Breschi L, Mannello F, Mazzoni A, Carvalho RM, Tjäderhane L, Tay FR, Pashley DH: Activation of gelatinolytic/collagenolytic activity in dentin by self-etching adhesives. Eur J Oral Sci 2006;114:160-166.
25.
Niu LN, Zhang L, Jiao K, Li F, Ding YX, Wang DY, Wang MQ, Tay FR, Chen JH: Localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in human coronal dentin. J Dent 2011;39:536-542.
26.
Palosaari H, Pennington CJ, Larmas M, Edwards DR, Tjaderhane L, Salo T: Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue. Eur J Oral Sci 2003;111:117-127.
27.
Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, Sorsa T, Gustafsson A: Salivary biomarkers of oral health - a cross-sectional study. J Clin Periodontol 2013a;40:140-147.
28.
Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, Sorsa T, Gustafsson A: Salivary biomarkers for detection of systemic diseases. PLoS One 2013b;8:e61356.
29.
Rayment SA, Liu B, Soares RV, Offner GD, Oppenheim FG, Troxler RF: The effects of duration and intensity of stimulation on total protein and mucin concentrations in resting and stimulated whole saliva. J Dent Res 2001;80:1584-1587.
30.
Santos J, Carrilho M, Tervahartiala T, Sorsa T, Breschi L, Mazzoni A, Pashley D, Tay F, Ferraz C, Tjäderhane L: Determination of matrix metalloproteinases in human radicular dentin. J Endod 2009;35:686-689.
31.
Séguier S, Gogly B, Bodineau A, Godeau G, Brousse N: Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 2001;72:1398-1406.
32.
Sorsa T, Ding YL, Ingman T, Salo T, Westerlund U, Haapasalo M, Tschesche H, Konttinen YT: Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol 1995;22:709-717.
33.
Sorsa T, Suomalainen K, Uitto VJ: The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. Arch Oral Biol 1990;35(suppl):193S-196S.
34.
Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mäntylä P: Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321.
35.
Sorsa T, Tjäderhane L, Salo T: Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-318.
36.
Sulkala M, Larmas M, Sorsa T, Salo T, Tjäderhane L: The localization of matrix metalloproteinase-20 (MMP-20, enamelysin) in mature human teeth. J Dent Res 2002;81:603-607.
37.
Sulkala M, Tervahartiala T, Sorsa T, Larmas M, Salo T, Tjäderhane L: Matrix metalloproteinase-8 (MMP-8) is the major collagenase in human dentin. Arch Oral Biol 2007;52:121-127.
38.
Sulkala M, Wahlgren J, Larmas M, Sorsa T, Teronen O, Salo T, Tjäderhane L: The effects of MMP inhibitors on human salivary MMP activity and caries progression in rats. J Dent Res 2001;80:1545-1549.
39.
Tersariol IL, Geraldeli S, Minciotti CL, Nascimento FD, Pääkkönen V, Martins MT, Carrilho MR, Pashley DH, Tay FR, Salo T, Tjäderhane L: Cysteine cathepsins in human dentin-pulp complex. J Endod 2010;36:475-481.
40.
Tezvergil-Mutluay A, Mutluay M, Seseogullari-Dirihan R, Agee KA, Key WO, Scheffel DLS, Bresci L, Mazzoni A, Tjäderhane L, Nishitani Y, Tay FR, Pashley DH: Effect of phosphoric acid on the degradation of human dentin matrix. J Dent Res 2013;1:87-91.
41.
Tjäderhane L, Larjava H, Sorsa T, Uitto VJ, Larmas M, Salo T: The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res 1998;77:1622-1629.
42.
Tjäderhane L, Sulkala M, Sorsa T, Teronen O, Larmas M, Salo T: The effect of MMP inhibitor metastat on fissure caries progression in rats. Ann NY Acad Sci 1999;878:686-688.
43.
Uitto VJ, Suomalainen K, Sorsa T: Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res 1990;25:135-142.
44.
van Strijp AJ, van Steenbergen TJ, de Graaff J, ten Cate JM: Bacterial colonization and degradation of demineralized dentin matrix in situ. Caries Res 1994;28:21-27.
45.
van Strijp AJ, van Steenbergen TJ, ten Cate JM: Bacterial colonization of mineralized and completely demineralized dentin in situ. Caries Res 1997;31:349-355.
46.
Vilen ST, Salo T, Sorsa T, Nyberg P: Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013;2013:929595.
47.
Vuotila T, Ylikontiola L, Sorsa T, Luoto H, Hanemaaijer R, Salo T, Tjäderhane L: The relationship between MMPs and pH in whole saliva of radiated head and neck cancer patients. J Oral Pathol Med 2002;31:329-338.
48.
Wu AJ, Lafrenie RM, Park C, Apinhasmit ZJ, Chen H, Birkedal-Hansen H, Yamada KM, Stetler-Stevenson WG, Baum BJ: Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase) by interferon-γ in a human salivary cell line. J Cell Physiol 1997;171:117-124.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.